04/03/2007
Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Dose Escalation Trial with TovaxinTM for Multiple Sclerosis


03/20/2007
Houston Technology Center Announces $2 Million Award to PLx Pharma Inc., $794,520 Award to Molecular LogiX Inc. by the Texas Emerging Technology Fund


03/19/2007
Opexa Reports Year End 2006 Financial Results


03/01/2007
Kryptiq Applauds Steps to Improve Healthcare Efficiency and Patient–Centered Care


02/14/2007
Opexa Therapeutics Launches Tovaxin™ Clinical Trial Website for Multiple Sclerosis


12/07/2006
Kryptiq Recognized as an Oregon Most Admired Company
Company Honored as One of the State’s Top Ten Technology Companies


11/13/2006
Opexa Reports Third Quarter Financial Results


11/06/2006
Opexa Begins Dosing Patients in Phase IIb Trial of Tovaxin™ for Multiple Sclerosis


10/31/2006
Opexa Therapeutics to Present at Rodman & Renshaw Eighth Annual Healthcare Conference


10/23/2006
Opexa Therapeutics to Present at C.E. Unterberg, Towbin Life Sciences Investor Conference


10/04/2006
EnVivo Secures $24 Million in Series C Financing


09/19/2006
Sapphire Therapeutics, Inc. Licenses Ghrelin Mimetic From Novo Nordisk
Ipamorelin to Enter Phase II for Postoperative Ileus


09/18/2006
Opexa Commences Phase IIb Multiple Sclerosis Study
Reports Positive Phase I/II Data
Provides Update on Preclinical Progress


09/15/2006
Opexa Therapeutics Inc. (OPXA) CEO to Ring The NASDAQ Stock Market Closing Bell


09/14/2006
Oregon Investment Fund Selects Kryptiq for First Direct Investment
Portland-based healthcare company completes C round from current investors and Oregon Investment Fund


09/01/2006
Opexa Shares to Trade on NASDAQ Global Market


08/25/2006
Sapphire Therapeutics, Inc. Expands Drug Development Team; New CEO, Board Appointment


08/14/2006
Opexa Reports Second Quarter Financial Results


06/26/2006
Scientists at Opexa Therapeutics Generate Human Insulin-Producing Islet Clusters in Culture from Monocyte-Derived Stem Cells


06/19/2006
PharmaFrontiers Changes Name to Opexa Therapeutics; New Ticker Symbol is OPXA


06/16/2006
PharmaFrontiers Appoints Michael Richman to Board of Directors


06/06/2006
PharmaFrontiers to Present at Marcus Evans Conference, "Facing Stem Cell Research Challenges"


05/23/2006
EnVivo Expands Management Team as Company Prepares First Drugs for Clinical Trials


05/15/2006
PharmaFrontiers Reports First Quarter 2006 Results


05/03/2006
PharmaFrontiers Names Lynne Hohlfeld Vice President of Finance


05/01/2006
PerkinElmer Acquires Spectral Genomics, Inc. Strengthening Capabilities in Screening and Diagnostics; Leading-Edge Molecular Karyotyping Technology Expected to Drive Advances in Prenatal and Neonatal Research and Disease Detection


04/17/2006
PharmaFrontiers Completes $23 Million Financing to Advance Therapeutics; Plans Reverse Stock Split


04/17/2006
PharmaFrontiers Appoints Gregory Bailey, M.D. and Scott Seaman, CPA, to Board of Directors


03/31/2006
PharmaFrontiers Reports Year End 2005 Financial Results


03/28/2006
PharmaFrontiers to Present Data on Adult Human T-Cell and Stem Cell Technologies at the International Society for Cellular Therapy Annual Meeting


03/22/2006
PharmaFrontiers to Present Tovaxin(TM) Research at Consortium of Multiple Sclerosis Centers' Annual Meeting


03/03/2006
Julia Wren presents at 2006 AUTM Annual Meeting


03/02/2006
Onyx and Kryptiq Join Forces to Improve Healthcare Provider Management Integration of systems increases efficiencies and controls legal risks through improved management of the healthcare provider life cycle


03/02/2006
Dr. Buz Brown leads panel at 2006 AUTM Annual Meeting


02/23/2006
Kryptiq CEO Presents Testimony to Subcommittee of U.S. House of Representatives Machuca Recommends Prioritization of Organic RHIO Expansion While Limiting Additional Spending on Centralized or Federated Models


02/13/2006
Providence Medical Group Releases Results of Diabetes Study Kryptiq’s CareManager™ Diabetes Module Leads to a 58 percent Improvement in the Number of Patients with Diabetes who Achieved Control of their Cholesterol and Blood Pressure Levels


02/06/2006
MedcomSoft and Kryptiq Announce Technology Partnership – Integrated Solution to be Showcased @ HIMSS Users of MedcomSoft Record™ 2006 will now have access to integrated patient portal and secure messaging integrated with their EMR


02/02/2006
Kryptiq Releases Coronary Heart Disease Module Software Helps Physicians Win the Battle Against Leading Cause of Death in America


01/31/2006
Kryptiq Customer Base Grows Over 100 Percent in 2005 Award-Winning Connectivity Solutions Solve Key Healthcare Challenges Today


01/17/2006
Sapphire Therapeutics, Inc. Appoints New Director and Scientific Advisory Board to Support Oncologic and Metabolic Pipeline Development


01/17/2006
PharmaFrontiers Acquires Autologous T Cell Vaccine Rights for Rheumatoid Arthritis


01/06/2006
Sapphire Therapeutics, Inc. Builds Drug Development Team Through New Hires and Promotion


01/05/2006
Physicians in Florida Connect Pay-for-Performance to Quality Healthcare Melbourne Internal Medicine Associates Implements Kryptiq CareManager™ to Create Disease Management Benchmarks


12/15/2005
Sapphire Therapeutics, Inc.’s Oral Ghrelin Mimetic Shows Potential for Treating Cancer Anorexia/Cachexia


12/14/2005
Kryptiq Honored by GE Centricity® Users With 2005 Achievements and Innovations Award

Kryptiq’s ClinicalMessenger™ 3.0 Wins Best Vendor Innovation


12/01/2005
PharmaFrontiers Appoints Mathilda Mandel to Clinical Advisory Board


11/30/2005
[KUHF] New Grant for Nano-Technology Cancer Research (by Laurie Johnson)


11/23/2005
Bacteria firm to grow in Athens (Published in the Athens Banner-Herald on 11.23.2005)


11/15/2005
PharmaFrontiers Shareholders Approve Increase in Authorized Shares at Special Meeting


11/15/2005
PharmaFrontiers Reports Third Quarter 2005 Financial Results; Provides Update on Research & Development Activities


11/07/2005
Providence Health Plans Will Speak at AHIP Business Forum Session Reveals Key Steps to Successful Health Plan Contract Management Implementation with Kryptiq Guardian Contract Manager


10/31/2005
PharmaFrontiers Tovaxin(TM) Phase IIb Multiple Sclerosis Clinical Trial Protocol Accepted by FDA


10/26/2005
PharmaFrontiers Corp. Elects Interim Chairman


10/18/2005
Wallstreet Reporter Interviews Sapphire Therapeutics


10/17/2005
Kryptiq CEO to Speak at California Association of Health Plans

Expert Panel to Discuss Real Life Applications of Electronic Health Records to Facilitate Collaboration between Health Plans, Providers, and Patients


10/05/2005
Rejuvenon Corporation. changes name to Sapphire Therapeutics; Closes on second tranche of Series B financing


10/03/2005
PharmaFrontiers Presents Positive Tovaxin(TM) Research at International Multiple Sclerosis Meeting


09/29/2005
Fairway Medical Technologies Receives $2.9 Million National Cancer Institute Nanotechnology Grant for Early Breast Cancer Detection Technology


09/29/2005
[Houston Business Journal] Fairway gets grant for development of breast cancer technology


09/08/2005
Physicians Take Charge of Health for Patients with Chronic Diseases

DecaturMemorial Hospital Deploys New CareManager™ Surveillance System From Kryptiq to Better Serve Chronically Ill Patients


08/16/2005
PharmaFrontiers Reports Second Quarter 2005 Financial Results; Provides Research Update


08/10/2005
PharmaFrontiers to Present Tovaxin(TM) Research at International Multiple Sclerosis Meeting


07/25/2005
BCM Technologies president named to board of bioscience accelerator


07/20/2005
Rejuvenon’s RC-8800 for Prostate Cancer Enters Human Testing
RC-1291 Ghrelin Mimetic Starts Phase II in Cachexia


07/01/2005
PHARMAFRONTIERS CORP Files SEC form 8-K, Sale of Equity


06/27/2005
EnVivo Appoints Kees Been as Chief Executive Officer


06/20/2005
PharmaFrontiers Completes $5.08 MM Financing


06/14/2005
Biopharma Agennix To Seek Up To $50M For Phase III Trials


06/13/2005
Agennix's Topical Talactoferrin Improved Healing of Diabetic Ulcers


06/08/2005
PharmaFrontiers Presented Preliminary Tovaxin Clinical Plans at Multiple Sclerosis Centers Meeting


06/03/2005
PharmaFrontiers Announces Positive Interim Results of Two Phase I/II Clinical Trials for Multiple Sclerosis


05/24/2005
Kryptiq Connectivity Summit Fuels Healthcare Transformation Momentum CEO Directs Industry to Create National Health Information Network One Physician Office, One Workflow at a Time


05/19/2005
INHS Selects Kryptiq to Connect Regional Health Information System

Kryptiq ClinicalMessenger Facilitates Fluid Exchange of Health Information


05/17/2005
PharmaFrontiers Adds Three Members to Its Scientific Advisory Board


05/17/2005
Agennix's Oral Talactoferrin Improved Response Rates, Time to Progression and Duration of Response When Combined with First-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer Presented at ASCO


05/16/2005
Memorial Family Care Deploys Kryptiq ClinicalMessenger 3.0

New Software Fosters Efficient Health Information Exchange in Communities to Inform Clinical Practices and Interconnect Clinicians


05/03/2005
PharmaFrontiers Selects INC Research as Development Partner for its Novel Multiple Sclerosis Therapy


04/29/2005
ADViSYS: Electroporation, a step closer to efficient vaccine delivery


04/26/2005
PharmaFrontiers Announces Dr. Eliezer Huberman to Chair Scientific Advisory Board


04/19/2005
Agennix's Oral Talactoferrin Substantially Improved Response Rates When Combined with First-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer


04/15/2005
PharmaFrontiers Provides Update, Financial Results


03/30/2005
Agennix Raises $22 Million in Private Financing


02/28/2005
Spectral Genomics, Inc. Names GE Healthcare as Its Exclusive International Distributor


02/14/2005
Kryptiq Corporation and GE Healthcare Sell ClinicalMessenger™ to Community Health Networks to Extend Reach of Electronic Medical Records

Kryptiq and GE Healthcare Provide Integrated Solution for Electronic Sharing of Patient Information Across Community Health Network and 500 Affiliated Physicians


02/14/2005
Kryptiq Clinical Messaging Integrated with Electronic Health Records Saves Healthcare Industry $10.37 per Referral e-Referral Study Validates Business Case and Usability for Community Adoption of New Cost-Effective and Efficient Information Sharing Model


02/14/2005
Demand for EHR Connectivity in Community Settings Drives Growth of Kryptiq Corp. Inland Northwest Health Services, Community Health Network, and Providence Health System Demonstrate Trend Toward Adoption of Clinical Messaging Technologies


02/14/2005
Kryptiq Introduces Disease Management Product Developed for Providers MedStar Health Adopts CareManager™ to Leverage Existing Medical Record Data to Improve Care for Patients with Chronic Illnesses


02/08/2005
Methylgene and EnVivo sign HDAC Collaboration Agreement


01/19/2005
Kryptiq Aligns with Newt Gingrich and The Center for Health Transformation
National Effort Will Help Realize Improved Healthcare for All Americans


01/10/2005
Rejuvenon’s RC-1291 Ghrelin Mimetic Receives Fast Track Designation from FDA for Cancer Anorexia/Cachexia


12/09/2004
BCM Technologies names two new directors to the Board, James Hackett and Alan Buckwalter.


11/15/2004
Spectral Genomics, Inc. Announces release of SpectralWare Web 2.2


11/15/2004
EnVivo Pharmaceuticals Secures $23 Million Series B Funding


09/29/2004
Kryptiq Signs Deal with Northwest Permanente to Automate Contract Management


09/28/2004
Fairway Medical Technologies, Inc. Expands Facilities


09/27/2004
MeritCare Takes First Step Towards Connected Health Network
Adoption of Clinical Messaging From Kryptiq Corp. Facilitates Adoption of National Health Information Infrastructure


08/30/2004
Fairway Medical Technologies receives a major grant to study breast cancer.


08/18/2004
Agennix Data Published in the International Journal of Cancer


08/16/2004
EnVivo Announces Hiring of Vice President of Chemistry


07/14/2004
EnVivo To Pay $1.1M For Licensing And Research Agreement With MethylGene
By John Galante


07/13/2004
MethylGene and EnVivo Pharmaceuticals to collaborate in Neurodegenerative Diseases


06/23/2004
Rejuvenon Raises $37 Million in Series B Venture Financing; New Board Members Named


06/09/2004
VAMC and Agennix Release Lactoferrin Cancer Trial Results at ASCO


05/25/2004
Agennix Receives SBIR Asthma Funding, Presents at ATS Meeting


05/03/2004
Industry Leaders Rally Around Connectivity Advancements in Healthcare
The 2004 Healthcare Connectivity Summit Unveils Roadmap for Better Care at Lower Costs Through Integration of Clinical Information Systems by 2010


04/19/2004
Kryptiq Sponsors First Annual Healthcare Connectivity Summit
Industry Leaders to Present Practical Strategies for Achieving Connectivity Among Healthcare Systems and Enabling Patient Data to be Securely Accessible to Involved Parties


03/31/2004
Medical Providers Across U.S. Adopt Secure Online Services from Kryptiq to Improve Access to Physicians
Kryptiq’s Integrated Web Portal Makes it Easier for Patients to Communicate With Physicians, Schedule Appointments, Access Personal Medical Information and More


03/30/2004
Agennix Presents Positive RhLF Cancer Results at AACR Meeting


03/22/2004
Kryptiq Joins AAFP Partners for Patients in EHR Movement
Kryptiq Joins American Academy of Family Physicians to Enable Electronic Health Record Portability in Today’s Medical Practices


03/11/2004
InteGreat Offers Comprehensive Patient Portal Through Key Partnerships


03/10/2004
Spectral Genomics, Inc. Acquires Bacterial Barcodes, Inc. Closes $9.3 Million Series B Financing


03/09/2004
Agennix Composition of Matter Patent on Recombinant Human Lactoferrin Upheld in Europe


02/23/2004
Kryptiq Introduces New Physician Office Web Portal
CareCatalyst™ Streamlines Patient/Clinic Communications and Integrates with Clinical Systems to Further Enable the Connected Medical Practice


02/23/2004
Kryptiq Unveils New Solution for Managing Healthcare Insurance Contracts
Kryptiq Guardian Contract Manager™ Provides End-to-End Solution for Managing all Cycles of Payer-Provider Contracts


02/17/2004
Kryptiq to Demonstrate Technologies for Connecting Healthcare at HIMSS
Kryptiq Announces Support of CCR Initiative and Introduces New Solutions that Enable Information Portability, Accessibility and Clinical System Interoperability


02/04/2004
Kryptiq Selected by Eastern Maine Healthcare for Clinical Messaging and Systems Connectivity
Large East Coast Health System to Securely Connect Patients and Doctors Throughout Maine as Both a Customer and Reseller


01/26/2004
Kryptiq Suite of Products Selected by Capital Region Healthcare
Large New Hampshire Health System Will Connect Patients and Doctors Securely Using Kryptiq’s Clinical Messaging System and Web-based forms tool


01/19/2004
Kryptiq Corporation Acquires T.H.I.S. Computer Solution, Inc.
Kryptiq Provides Transparency to Contract Management for US Health Insurance Providers


12/05/2003
EnVivo Appoints Several Leaders to Its Scientific Advisory Board


12/03/2003
Austin Diagnostic Clinic Selects Kryptiq for Secure Messaging
One of Nation’s Largest Physician Owned Clinics Installs Secure Messaging to Improve Clinical Workflow and Quality of Care


11/17/2003
EnVivo Announces Key Additions to Its Management Team


11/10/2003
Kryptiq Corporation Acquires MedShape
Document Management Solutions and Interface Engine Technology From MedShape Expands Kryptiq's Existing Healthcare Workflow Messaging Platform


10/27/2003
EnVivo Pharmaceuticals Has Moved to Watertown, Massachusetts


10/20/2003
Spectral Genomics Forges License Agreement with Affymetrix


10/15/2003
New DNA Array at Spectral Genomics, Inc.


10/13/2003
The Heart Institute of Spokane Implements Kryptiq's Secure Messaging Solution for Communicating Confidential Health Information
Increased Workflow Efficiency, Improved Quality of Care and HIPAA Compliance Drive Adoption of Kryptiq Secure Email


10/01/2003
Brown names Swartley as the Senior Vice President of BCMT.


09/23/2003
Bacterial Barcodes to Incorporate Agilent Technologies 2100 Bioanalyzer as Part of Its DiversiLab System


09/17/2003
Agennix Inc. Receives $850,000 NIH Funding to Support Clinical Trials of rhLF Gel for Treatment of Patients with Diabetic Foot Ulcers


09/10/2003
Kryptiq Extends Leadership and Presence in National Healthcare Market
Leading Provider of Messaging-Based Workflow Solutions Attracts Industry Veterans


08/13/2003
Michigan State University Health Selects Kryptiq for Connecting Patient Health Data
Integrated Electronic Medical Record Solution Streamlines Healthcare Communications


08/11/2003
New CEO at Spectral Genomics, Inc.


08/04/2003
Spectral Genomics, Inc. Names Robert Johnson President and COO


07/30/2003
Kryptiq Corporation Releases E-Gateway
New Security and Workflow Solution Connects Critical Health Data Using Email


07/22/2003
Kryptiq Corporation Acquires RosettaMed
Company Adds Forms Capability to Automated Healthcare Workflows


07/18/2003
Brown is named president of BCM Technologies Inc.


07/16/2003
Stopping rogue infectious agents in the nick of time


07/08/2003
CareOregon Selects Kryptiq for HIPAA Compliance


06/30/2003
Agennix appoints Dr. Frank Young Chairman of its Board of Directors


06/18/2003
Agennix Inc. Presents Positive Results Showing Accelerated Wound Healing and Wound Closure with Topical Recombinant Human Lactoferrin


06/05/2003
BCMT/BioHouston Life Science Conference Summary


05/22/2003
VAMC and Agennix Successfully Complete Safety Phase of Lactoferrin Cancer Trial


04/30/2003
Kryptiq Joins GE Medical Systems Partner Program
New Solution Migrates Logician Users from Fax to Secure Email


04/23/2003
Legacy Health System Selects Kryptiq For Email Security
Increased Security of Patient Data at Largest Oregon-Based, Not-For-Profit Healthcare System


02/26/2003
BCM Technologies / BioHouston Life Science Conference


02/11/2003
Bacterial BarCodes closes $6 Million Series C Financing


01/16/2003
BCM Technologies Forms Venture Advisory Board


10/24/2002
wired.MD, Inc. and Kryptiq Corp. Combine Forces to Provide First Out-of-Office Interactive Patient Communication and Education Solution
Video Patient Education Software and HIPAA-Compliant Secure Email DeliverCustomized and Confidential Information to Patients with Internet Access


10/10/2002
Kryptiq Launches Secure Email Technology Targeting Health Care Organizations
Integrated Software Application Streamlines Business Processes and Facilitates HIPAA Compliance


10/03/2002
EnVivo Pharmaceuticals closes $14.7M Series A round led by Fidelity Biosciences Group - David A. Lowe, Ph.D. appointed as President and CEO


10/01/2002
EnVivo Awarded NIH Grant to Develop Technology for CNS Drug Discovery


09/30/2002
TIPAAA Selects Kryptiq as Partner to Provide Secure Messaging Solutions
Healthcare Community To Benefit From Streamlined Business Processes and HIPAA Compliance


09/17/2002
Agennix and DSM Pharmaceutical Products announce opening of recombinant human lactoferrin manufacturing facility


09/04/2002
Kryptiq Delivers Healthcare Productivity Through New Approach to Secure Email
Community of Healthcare Providers Connected through Improved Workflow Solutions


05/29/2002
Agennix Completes $20 Million Private Placement Financing


05/01/2002
Start-Up : In Focus : BCM Technologies, Inc.


05/14/2001
Dr. Waun Ki Hong, head of M.D. Anderson's Division of Cancer Medicine joins Agennix's Scientific Advisory Board


05/10/2001
Agennix Receives Broad Patent Covering Production of Human Lactoferrin in Eukaryotic Cells